SCLX - Scilex Holding Company
IEX Last Trade
1.15
0.040 3.478%
Share volume: 642,374
Last Updated: Fri 30 Aug 2024 09:59:40 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.11
0.04
3.60%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2023-05-12 | 2023-08-11 | 2023-11-14 | 2024-03-12 | 2024-05-13 | |
| Total revenue | 10.582 M | 12.582 M | 10.117 M | 13.462 M | 10.884 M | |
| Cost of revenue | 3.591 M | 4.177 M | 3.392 M | 4.521 M | 3.840 M | |
| Gross profit | 6.991 M | 8.405 M | 6.725 M | 8.941 M | 7.044 M | |
| 20.23% | -19.99% | 32.95% | -21.22% | |||
| Operating expenses | 31.437 M | 30.193 M | 44.503 M | 26.254 M | 32.386 M | |
| Selling general and admin | 28.701 M | 26.989 M | 40.431 M | 23.520 M | 29.278 M | |
| Research and development | 2.736 M | 3.204 M | 4.072 M | 2.734 M | 3.108 M | |
| Total expenses | 36.055 M | 35.396 M | 48.922 M | 31.801 M | 37.253 M | |
| -1.83% | 38.21% | -35.00% | 17.14% | |||
| Operating income | -25.473 M | -22.814 M | -38.805 M | -18.339 M | -26.369 M | |
| Ebit | -25.473 M | -22.814 M | -38.805 M | -18.339 M | -26.369 M | |
| Pretax income | -30.745 M | -26.652 M | -35.529 M | -21.392 M | -24.377 M | |
| -13.31% | 33.31% | -39.79% | 13.95% | |||
| Income tax | 8.000 K | -3.000 K | 0.000 | 8.000 K | 0.000 | |
| Net income basic | -30.753 M | -26.649 M | -35.529 M | -21.400 M | -24.377 M | |
| 13.35% | -33.32% | 39.77% | -13.91% | |||
| Net income | -30.753 M | -26.649 M | -35.529 M | -21.400 M | -24.377 M | |
| 13.35% | -33.32% | 39.77% | -13.91% |